Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

Georg B EhretToby Johnson


Blood pressure is a heritable trait influenced by several biological pathways and responsive to environmental stimuli. Over one billion people worldwide have hypertension (≥140 mm Hg systolic blood pressure or  ≥90 mm Hg diastolic blood pressure). Even small increments in blood pressure are associated with an increased risk of cardiovascular events. This genome-wide association study of systolic and diastolic blood pressure, which used a multi-stage design in 200,000 individuals of European descent, identified sixteen novel loci: six of these loci contain genes previously known or suspected to regulate blood pressure (GUCY1A3-GUCY1B3, NPR3-C5orf23, ADM, FURIN-FES, GOSR2, GNAS-EDN3); the other ten provide new clues to blood pressure physiology. A genetic risk score based on 29 genome-wide significant variants was associated with hypertension, left ventricular wall thickness, stroke and coronary artery disease, but not kidney disease or kidney function. We also observed associations with blood pressure in East Asian, South Asian and African ancestry individuals. Our findings provide new insights into the genetics and biology of blood pressure, and suggest potential novel therapeutic pathways for cardiovascular disease prevention.


Nov 10, 2013·JAMA Ophthalmology·Jane Z KuoJerome I Rotter
May 9, 2012·Cellular and Molecular Life Sciences : CMLS·Peter A Doris
Jun 28, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·P S WildStefan S Blankenberg
Feb 3, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Jens Schlossmann, Elisabeth Schinner
Jul 6, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Hakan R TokaAli Hariri
Aug 21, 2013·Biogerontology·Vanessa Gonzalez-Covarrubias
Oct 9, 2013·Molecular and Cellular Biochemistry·Neeta AdhikariJennifer L Hall
Mar 23, 2012·Current Atherosclerosis Reports·A J Marian
Feb 3, 2012·Current Diabetes Reports·Susann BlüherPeter E H Schwarz
Dec 14, 2011·Current Hypertension Reports·Nicholas J TimpsonGeorge Davey Smith
Dec 13, 2012·Current Hypertension Reports·Robrecht ThoonenEmmanuel S Buys
Dec 29, 2013·Current Hypertension Reports·John M FlackPhillip Levy
Aug 11, 2012·Environmental Health and Preventive Medicine·Akio KoizumiShinichiro Shimbo
Apr 12, 2012·Journal of Cardiovascular Translational Research·Jennifer L HallStephen S Rich
Mar 9, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Toru NabikaMinoru Isomura
Apr 6, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yasuharu TabaraMillennium Genome Project for Hypertension
Mar 30, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Fumihiko TakeuchiNorihiro Kato
Apr 6, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Norihiro Kato
Jun 29, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kei KamideHiromi Rakugi
Mar 13, 2012·Nature Genetics·Hélène Louis-Dit-PicardXavier Jeunemaitre
Dec 4, 2012·Nature Genetics·Momoko HorikoshiEarly Growth Genetics (EGG) Consortium
Dec 4, 2012·Nature Genetics·Panos DeloukasNilesh J Samani
Oct 8, 2013·Nature Genetics·Cristen J WillerGlobal Lipids Genetics Consortium
Jun 12, 2012·Nature Reviews. Drug Discovery·Nabil G Seidah, Annik Prat
Dec 2, 2011·The New England Journal of Medicine·Christopher J O'Donnell, Elizabeth G Nabel


Mar 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D B SchenkJ A Lewicki
Sep 23, 1994·Cell·H H Schmidt, U Walter
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·N MatsukawaOliver Smithies
Mar 10, 2001·Cell·R P LiftonD S Geller
Jan 18, 2005·Lancet·Patricia M KearneyJiang He
Apr 7, 2005·The Journal of Clinical Endocrinology and Metabolism·Karsten MüssigBaptist Gallwitz
Apr 18, 2006·Pharmacology & Therapeutics·Toshihiko IshimitsuHiroaki Matsuoka
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Andreas FriebeDoris Koesling
May 16, 2008·BMJ : British Medical Journal·Blood Pressure Lowering Treatment Trialists' CollaborationS MacMahon
Dec 6, 2008·American Journal of Hypertension·Tamra E MeyerEric Boerwinkle
Mar 7, 2009·Toxicology and Applied Pharmacology·Lei HeDaniel W Nebert
May 12, 2009·Nature Genetics·Daniel LevyCornelia M van Duijn
May 12, 2009·Nature Genetics·Christopher Newton-ChehPatricia B Munroe
Jun 26, 2010·Journal of the American Society of Nephrology : JASN·Julia B Lewis
Aug 6, 2010·Nature·Tanya M TeslovichSekar Kathiresan
Aug 17, 2010·BMC Medical Genetics·Nanfang LiJianhang Chang
Oct 12, 2010·Nature Genetics·Elizabeth K SpeliotesRuth J F Loos

Related Concepts

Genome-Wide Association Study
Diastolic Blood Pressure Measurement
Biochemical Pathway
EDN3 gene
GNAS gene
Coronary Artery Disease
Paired basic amino acid cleaving enzyme
Systolic Blood Pressure Measurement
Diastolic Blood Pressure
GUCY1B3 gene

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.